ETF PRO AIOctober 4, 2026
XPH SPDR S&P Pharmaceuticals ETF
Fund tearsheet · data as of the latest session · October 4, 2026
ONE YEAR OF DAILY CLOSES
0.35%expense ratio
$510Mfund assets
+13.6%return, YTD
+29.9%return, 1 year
−$39Mnet flow, 1 month
+$256Mnet flow, 1 year
23.2%realized volatility, 1y
-14.1%worst drawdown, 1y
Top ten holdings
| 1 | AMLX AMYLYX PHARMACEUTICALS | 2.04% |
| 2 | MBX MBX Biosciences | 2.72% |
| 3 | OMER OMEROS | 1.42% |
| 4 | DFTX Definium Therapeutics | 3.09% |
| 5 | CORT CORCEPT THERAPEUTICS | 1.70% |
| 6 | AMRX AMNEAL PHARMACEUTICALS | 1.72% |
| 7 | ETON ETON PHARMACEUTICALS | 1.30% |
| 8 | PRGO PERRIGO CO | 1.42% |
| 9 | ELVN ENLIVEN THERAPEUTICS | 2.09% |
| 10 | EWTX EDGEWISE THERAPEUTICS | 1.88% |
PREPARED WITH ETF PRO AI · PRIMARY MARKET DATA · INFORMATIONAL ONLY — NOT AN OFFER, RECOMMENDATION, OR INVESTMENT ADVICE · PAST PERFORMANCE DOES NOT GUARANTEE FUTURE RESULTS